|
PIKFYVE expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.14049999999644E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.50609999974394E-07 |
| Normal-vs-Stage2 |
5.077900E-02 |
| Normal-vs-Stage3 |
5.321400E-03 |
| Normal-vs-Stage4 |
1.236790E-03 |
| Stage1-vs-Stage2 |
2.402000E-01 |
| Stage1-vs-Stage3 |
4.303400E-01 |
| Stage1-vs-Stage4 |
8.261000E-01 |
| Stage2-vs-Stage3 |
6.901000E-01 |
| Stage2-vs-Stage4 |
3.553200E-01 |
| Stage3-vs-Stage4 |
5.049400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.53159999969088E-07 |
| Normal-vs-AfricanAmerican |
8.601300E-04 |
| Normal-vs-Asian |
1.676220E-02 |
| Caucasian-vs-AfricanAmerican |
4.654200E-01 |
| Caucasian-vs-Asian |
9.262800E-01 |
| AfricanAmerican-vs-Asian |
8.776400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.45389999986578E-07 |
| Normal-vs-Female |
1.017210E-01 |
| Male-vs-Female |
1.242600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.816700E-04 |
| Normal-vs-Extreme_Weight |
2.87110002439306E-09 |
| Normal-vs-Obese |
6.975100E-04 |
| Normal-vs-Extreme_Obese |
2.619600E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.452030E-01 |
| Normal_Weight-vs-Obese |
4.773400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.754400E-01 |
| Extreme_Weight-vs-Obese |
1.159820E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.150600E-01 |
| Obese-vs-Extreme_Obese |
2.992600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.141900E-02 |
| Normal-vs-Age(41-60Yrs) |
7.366000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.60849999880841E-08 |
| Normal-vs-Age(81-100Yrs) |
7.90620000000741E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.932800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.117560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.053900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.267800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.319600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.706600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.30380000030028E-07 |
| Normal-VS-Type2 PRCC |
2.75999999999055E-06 |
| Normal-VS-KIRP CIMP |
9.227600E-02 |
| Normal-VS-Unclassified PRCC |
1.957400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.087400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.148000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.020210E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.799200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.854000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.175600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.20990000532728E-08 |
| Normal-vs-N1 |
1.352210E-01 |
| Normal-vs-N2 |
1.276880E-03 |
| N0-vs-N1 |
5.584100E-02 |
| N0-vs-N2 |
5.488200E-01 |
| N1-vs-N2 |
2.244800E-01 |
|
|
